This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Knowing what to look for in no fee credit cards with benefits can enhance your financial strategy. Discover essential features to consider.
19,441 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...
Big tech often steals the AI spotlight, but overlooked, nimble players could outperform. This guide breaks down the r...
March's trading session brought a noticeable shift as airline stocks rallied amid easing fuel concerns. This piece br...
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
A high-profile White House move puts Silicon Valley on center stage. As trump appoints mark zuckerberg to a new scien...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
Super Micro Computer posted a margin-led earnings surprise that beat expectations and lifted full-year guidance, prom...
As 2026 unfolds, investors are watching novavax (nvax) 2026 earnings for clarity on demand, pipeline milestones, and ...
Looking ahead at geron (gern) 2026 earnings, this guide breaks down the catalysts, cash runway, and risks shaping the...
Sandisk has surged as AI infrastructure gains grab headlines. But can the rally last? This article lays out 3-year sc...